Your session is about to expire
← Back to Search
Single treatment arm for Pain
Phase 1
Waitlist Available
Led By Theodore Zanker, MD
Research Sponsored by The Connecticut Hospice Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up minimum 5 days
Awards & highlights
Study Summary
This trial is testing if medical marijuana can help with pain management and other symptoms in terminally ill patients.
Eligible Conditions
- Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ minumum 5 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~minumum 5 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
primary reduction of pain and reduction in overall opioid utilization
Secondary outcome measures
improved oxygen saturation
improvement in overall patient well being
improvement or prevention of nausea and vomiting
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Single treatment armExperimental Treatment1 Intervention
marijuana adjuvant treatment group utilizing scheduled opioid therapy in inpatient hospice hospital setting
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medical Marijuana
2017
Completed Phase 1
~360
Find a Location
Who is running the clinical trial?
The Connecticut Hospice Inc.Lead Sponsor
Theodore Zanker, MDPrincipal InvestigatorThe Connecticut Hospice Inc.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger